...
首页> 外文期刊>BMC Pediatrics >How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial
【24h】

How effective is tetracaine 4% gel, before a venipuncture, in reducing procedural pain in infants: a randomized double-blind placebo controlled trial

机译:静脉穿刺前丁卡因4%凝胶在减轻婴儿程序性疼痛方面的效果如何:一项随机双盲安慰剂对照试验

获取原文

摘要

Background Procedural pain relief is sub-optimal in neonates. Topical tetracaine provides pain relief in children. Evidence of its efficacy and safety in neonates is limited. The objective of this study was to assess the efficacy and safety of topical tetracaine on the pain response of neonates during a venipuncture. Methods Medically stable infants greater than or equal to 24 weeks gestation, requiring a venipuncture, were included. Following randomization and double blinding, 1.1 g of tetracaine or placebo was applied to the skin for 30 minutes. Participants received oral sucrose if they met local eligibility criteria. The venipuncture was performed according to a standard protocol. A medium effect size in the pain score (corresponding to about 2 point difference in the PIPP score) was considered clinically significant, leading to a sample size of 142 infants, with 80% statistical power. Local skin reactions and immediate adverse cardiorespiratory events were noted. The primary outcome, PIPP score at 1 minute, was analysed using an independent Student's t-test. Results One hundred and forty two infants were included, 33 +/- 4 weeks gestation, 2100 +/- 900 grams and 6 +/- 3 days of age. There was almost no difference in PIPP scores at 1 minute between groups (mean difference -0.09; 95% confidence interval [CI]: -1.68 to 1.50; P = . 91). Similarly, there were no differences in PIPP scores during the 2nd, 3rd and 4th minute. Duration of cry did not differ between the groups (median difference, 0; 95% CI, -3 to 0; P = . 84). The majority of infants in both groups received sucrose 24%. Sucrose had a significant effect on the PIPP score, as assessed by an ANOVA model (p = 0.0026). Local skin erythema was observed transiently in 11 infants (7 in the tetracaine and 4 in the placebo group). No serious side effect was observed. Conclusion Tetracaine did not significantly decrease procedural pain in infants undergoing a venipuncture, when used in combination with routine sucrose administration.
机译:背景程序减轻疼痛在新生儿中次优。外用丁卡因可减轻儿童疼痛。其在新生儿中的功效和安全性的证据有限。这项研究的目的是评估局部丁卡因对新生儿静脉穿刺过程中疼痛反应的有效性和安全性。方法包括需要静脉穿刺的大于或等于妊娠24周的医学稳定婴儿。随机分组和双盲后,将1.1 g丁卡因或安慰剂涂在皮肤上30分钟。如果参与者符合当地资格标准,则他们会接受口服蔗糖。根据标准方案进行静脉穿刺。疼痛评分的中等影响大小(相当于PIPP评分约有2点差异)被认为具有临床意义,导致142名婴儿的样本量具有80%的统计功效。注意到局部皮肤反应和立即不良心肺事件。主要结果(1分钟时的PIPP评分)使用独立的学生t检验进行了分析。结果包括142例婴儿,妊娠33 +/- 4周,2100 +/- 900克和6 +/- 3天。两组之间在1分钟时的PIPP评分几乎没有差异(平均值差异-0.09; 95%置信区间[CI]:-1.68至1.50; P =。91)。同样,在第二分钟,第三分钟和第四分钟期间,PIPP得分也没有差异。两组之间的哭泣持续时间没有差异(中位数差异为0; 95%CI为-3至0; P = 0.8)。两组的大多数婴儿都接受了24%的蔗糖。通过ANOVA模型评估,蔗糖对PIPP评分有显着影响(p = 0.0026)。在11例婴儿中短暂观察到局部皮肤红斑(丁卡因7例,安慰剂组4例)。没有观察到严重的副作用。结论与常规的蔗糖联合使用时,利他卡因并不能显着减轻经静脉穿刺的婴儿的程序性疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号